IRWD IRONWOOD PHARMACEUTICALS INC

8-K Current Report

Filed: March 11, 2026

Health Care

Pharmaceutical Preparations

IRONWOOD PHARMACEUTICALS INC (IRWD) 8-K current report filed with SEC EDGAR on March 11, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

Item 8.01: Other Events

AI Filing Analysis
8-K

Item 8.01 · Other Events

• Ironwood confirmed it met liquidity conditions required to lock in the Dec 31, 2028 maturity date on its revolving credit facility
• Failure to satisfy these conditions would have triggered an earlier maturity — confirmation removes that near-term refinancing risk

+2 more insights

Other IRONWOOD PHARMACEUTICALS INC 8-K Filings

8-K Feb 25, 2026

Get deeper insights on IRONWOOD PHARMACEUTICALS INC

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.